Otomagnetics is developing a non-invasive method to deliver drugs and other therapeutic payloads to inner and middle ear compartments, to the eye, and into the skin.
The inner ear is behind the blood-labyrinth barrier – vessels that supply blood to the inner ear have walls that are impermeable to most drug molecules, and thus it is a challenge to deliver therapy to treat inner ear diseases. Otomagnetics’ proprietary magnetic injection system has demonstrated drug delivery to the inner ear in animal models.
Otomagnetics’ technology has further shown drug delivery to the middle ear in animal models without the need to puncture the eardrum. Magnetic delivery to the middle ear may provide a non-invasive treatment use. In the future, the Otomagnetic’s technology may be investigated for delivering therapy into the eye, without needles.
